This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bioverativ Therapeutics Inc.. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Innovations of Brian M Thome
Introduction
Brian M Thome is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of formulations for Factor IX, which is crucial for blood coagulation.
Latest Patents
Brian M Thome holds 2 patents related to lyophilized Factor IX formulations. His latest patents provide pre-lyophilization formulations, reconstituted formulations, and lyophilate powder compositions comprising a Factor IX (FIX) polypeptide. These inventions also include methods for lyophilization to produce stable powder compositions that maintain the activity of the FIX polypeptide.
Career Highlights
Brian is currently employed at Bioverativ Therapeutics Inc., where he continues to innovate in the field of therapeutic formulations. His work focuses on improving the stability and efficacy of Factor IX, which is essential for patients with hemophilia.
Collaborations
He collaborates with talented coworkers such as Brandon W Leveille and Cherie Parkhurst-Lang, contributing to a dynamic research environment that fosters innovation.
Conclusion
Brian M Thome's contributions to the field of biotechnology through his patents and work at Bioverativ Therapeutics Inc. highlight his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile